264 related articles for article (PubMed ID: 7990109)
1. Bioisosteres of arecoline: 1,2,3,6-tetrahydro-5-pyridyl-substituted and 3-piperidyl-substituted derivatives of tetrazoles and 1,2,3-triazoles. Synthesis and muscarinic activity.
Moltzen EK; Pedersen H; Bøgesø KP; Meier E; Frederiksen K; Sánchez C; Løve Lembøl H
J Med Chem; 1994 Nov; 37(24):4085-99. PubMed ID: 7990109
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and muscarinic activity of a series of tertiary and quaternary N-substituted guvacine esters structurally related to arecoline and arecaidine propargyl ester.
Wolf-Pflugmann M; Lambrecht G; Wess J; Mutschler E
Arzneimittelforschung; 1989 May; 39(5):539-44. PubMed ID: 2757669
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and muscarinic receptor pharmacology of a series of 4,5,6,7-tetrahydroisothiazolo[4,5-c]pyridine bioisosteres of arecoline.
Pedersen H; Bräuner-Osborne H; Ball RG; Frydenvang K; Meier E; Bøgesø KP; Krogsgaard-Larsen P
Bioorg Med Chem; 1999 May; 7(5):795-809. PubMed ID: 10400332
[TBL] [Abstract][Full Text] [Related]
4. Muscarinic receptor 1 agonist activity of novel N-aryl carboxamide substituted 3-morpholino arecoline derivatives in Alzheimer's presenile dementia models.
Malviya M; Kumar YC; Mythri RB; Venkateshappa C; Subhash MN; Rangappa KS
Bioorg Med Chem; 2009 Aug; 17(15):5526-34. PubMed ID: 19595599
[TBL] [Abstract][Full Text] [Related]
5. In vivo muscarinic cholinergic mediated effects of Lu 25-109, a M1 agonist and M2/M3 antagonist in vitro.
Sánchez C; Arnt J; Didriksen M; Dragsted N; Moltzen Lenz S; Matz J
Psychopharmacology (Berl); 1998 Jun; 137(3):233-40. PubMed ID: 9683000
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and pharmacological evaluation of novel N-alkyl/aryl substituted thiazolidinone arecoline analogues as muscarinic receptor 1 agonist in Alzheimer's dementia models.
Sadashiva CT; Chandra JN; Kavitha CV; Thimmegowda A; Subhash MN; Rangappa KS
Eur J Med Chem; 2009 Dec; 44(12):4848-54. PubMed ID: 19717214
[TBL] [Abstract][Full Text] [Related]
7. Muscarinic receptor 1 agonist activity of novel N-arylthioureas substituted 3-morpholino arecoline derivatives in Alzheimer's presenile dementia models.
Malviya M; Kumar YC; Asha D; Chandra JN; Subhash MN; Rangappa KS
Bioorg Med Chem; 2008 Aug; 16(15):7095-101. PubMed ID: 18640043
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of 1-methyl-5-(pyrazol-3- and -5-yl- and 1, 2, 4-triazol-3- and 5-yl)-1, 2, 3, 6-tetrahydropyridine derivatives and their evaluation as muscarinic receptor ligands.
Del Giudice MR; Mustazza C; Borioni A; Gatta F; Tayebati K; Amenta F; Tucci P; Pieretti S
Arch Pharm (Weinheim); 2003 Jun; 336(3):143-54. PubMed ID: 12822179
[TBL] [Abstract][Full Text] [Related]
9. Annulated heterocyclic bioisosteres of norarecoline. Synthesis and molecular pharmacology at five recombinant human muscarinic acetylcholine receptors.
Bräuner-Osborne H; Ebert B; Brann MR; Falch E; Krogsgaard-Larsen P
J Med Chem; 1995 Jun; 38(12):2188-95. PubMed ID: 7783150
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and muscarinic activities of quinuclidin-3-yltriazole and -tetrazole derivatives.
Wadsworth HJ; Jenkins SM; Orlek BS; Cassidy F; Clark MS; Brown F; Riley GJ; Graves D; Hawkins J; Naylor CB
J Med Chem; 1992 Apr; 35(7):1280-90. PubMed ID: 1560440
[TBL] [Abstract][Full Text] [Related]
11. Effect of novel arecoline thiazolidinones as muscarinic receptor 1 agonist in Alzheimer's dementia models.
Chandra JN; Malviya M; Sadashiva CT; Subhash MN; Rangappa KS
Neurochem Int; 2008 Feb; 52(3):376-83. PubMed ID: 17719699
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological characterization of 1,4,5,6-tetrahydropyrimidine and 2-amino-3,4,5,6-tetrahydropyridine derivatives as selective m1 agonists.
Messer WS; Abuh YF; Liu Y; Periyasamy S; Ngur DO; Edgar MA; El-Assadi AA; Sbeih S; Dunbar PG; Roknich S; Rho T; Fang Z; Ojo B; Zhang H; Huzl JJ; Nagy PI
J Med Chem; 1997 Apr; 40(8):1230-46. PubMed ID: 9111297
[TBL] [Abstract][Full Text] [Related]
13. Aliphatic and heterocyclic analogues of arecaidine propargyl ester. Structure-activity relationships of mono- and bivalent ligands at muscarinic M1 (M4), M2 and M3 receptor subtypes.
Moser U; Gubitz C; Galvan M; Immel-Sehr A; Lambrecht G; Mutshcler E
Arzneimittelforschung; 1995 Apr; 45(4):449-55. PubMed ID: 7779140
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and serotonergic activity of N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethylamine and analogues: potent agonists for 5-HT1D receptors.
Street LJ; Baker R; Davey WB; Guiblin AR; Jelley RA; Reeve AJ; Routledge H; Sternfeld F; Watt AP; Beer MS
J Med Chem; 1995 May; 38(10):1799-810. PubMed ID: 7752204
[TBL] [Abstract][Full Text] [Related]
15. Effect of novel N-aryl sulfonamide substituted 3-morpholino arecoline derivatives as muscarinic receptor 1 agonists in Alzheimer's dementia models.
Kumar YC; Malviya M; Chandra JN; Sadashiva CT; Kumar CS; Prasad SB; Prasanna DS; Subhash MN; Rangappa KS
Bioorg Med Chem; 2008 May; 16(9):5157-63. PubMed ID: 18359231
[TBL] [Abstract][Full Text] [Related]
16. Muscarinic cholinergic agonists and antagonists of the 3-(3-alkyl-1,2,4-oxadiazol-5-yl)-1,2,5,6-tetrahydropyridine type. Synthesis and structure-activity relationships.
Sauerberg P; Kindtler JW; Nielsen L; Sheardown MJ; Honoré T
J Med Chem; 1991 Feb; 34(2):687-92. PubMed ID: 1995893
[TBL] [Abstract][Full Text] [Related]
17. Selective, centrally acting serotonin 5-HT2 antagonists. 2. Substituted 3-(4-fluorophenyl)-1H-indoles.
Andersen K; Perregaard J; Arnt J; Nielsen JB; Begtrup M
J Med Chem; 1992 Dec; 35(26):4823-31. PubMed ID: 1336054
[TBL] [Abstract][Full Text] [Related]
18. Muscarinic subtype affinity and functional activity profile of 1-methyl-2-(2-methyl-1,3-dioxolan-4-yl)pyrrolidine and 1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine derivatives.
Dei S; Angeli P; Bellucci C; Buccioni M; Gualtieri F; Marucci G; Manetti D; Matucci R; Romanelli MN; Scapecchi S; Teodori E
Biochem Pharmacol; 2005 Jun; 69(11):1637-45. PubMed ID: 15896343
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationships of new analogues of arecaidine propargyl ester at muscarinic M1 and M2 receptor subtypes.
Moser U; Lambrecht G; Wagner M; Wess J; Mutschler E
Br J Pharmacol; 1989 Feb; 96(2):319-24. PubMed ID: 2924082
[TBL] [Abstract][Full Text] [Related]
20. Tetrazole and triazole as bioisosteres of carboxylic acid: discovery of diketo tetrazoles and diketo triazoles as anti-HCV agents.
Song WH; Liu MM; Zhong DW; Zhu YL; Bosscher M; Zhou L; Ye DY; Yuan ZH
Bioorg Med Chem Lett; 2013 Aug; 23(16):4528-31. PubMed ID: 23856047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
